Menstrual Blood Stem Cells in Poor Ovarian Responders

PHASE3CompletedINTERVENTIONAL
Enrollment

180

Participants

Timeline

Start Date

June 21, 2020

Primary Completion Date

September 22, 2021

Study Completion Date

October 22, 2022

Conditions
Poor Ovarian ResponseInfertility, Female
Interventions
BIOLOGICAL

Autologous Menstrual Blood Stem Cells

The menstrual blood of patients in the MenSCs treatment group was collected in sterile menstrual cups on the second day of menstruation, and directly transferred to a class B clean room for MSC isolation and culture. All cell quality control studies were performed prior to the International Conference of Harmonization Q2 (ICH Q2) guidelines. The density of the final product was 20×106 cells/ml. 150 μl of the prepared suspension was injected intravaginally into each ovary of the patient under general anaesthesia

Trial Locations (1)

Unknown

Avicenna Research Institute, Tehran

Sponsors
All Listed Sponsors
lead

Avicenna Research Institute

OTHER